Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 5189 (MIR5189) is a predicted or annotated human non-coding RNA belonging to the large microRNA (miRNA) family. MicroRNAs are ~22-nucleotide RNAs that regulate gene expression post-transcriptionally, primarily by binding complementary sequences in the 3’ untranslated regions of target mRNAs, resulting in translational repression or mRNA degradation. MiRNAs can be tissue-specific, have diverse isoforms (isomiRs), and play major roles in cell differentiation, proliferation, apoptosis, and metabolism. However, there are no published functional, disease, or pharmacological data specific to MIR5189. MIR5189 is absent from curated drug-target databases and not established as a biomarker or therapeutic target. Note on correctness and evidence: - MIR5189 is a correctly annotated human microRNA locus in some databases (e.g., miRBase), but there is no experimental evidence or literature suggesting it is a validated therapeutic target, nor reported functions, disease relevance, or drug interactions specific to MIR5189. - If the intention was to find a drug target, enzyme, receptor, transporter, or similar actionable therapeutic molecule, MIR5189 does not qualify. - If the intention was to extract data on the biology or medical significance of MIR5189, such information is currently unavailable in published sources. Most microRNAs have not been deeply characterized, and MIR5189 appears to be one of these. Summary assessment: - MIR5189 is a human microRNA (non-coding RNA), not a druggable target (e.g., enzyme, receptor, transporter), and has no known therapeutic, biomarker, or disease-specific function in the available scientific literature. - Reporting MIR5189 as a target would be incorrect in most therapeutic or drug discovery contexts, since it is not established as a validated or actionable target. Key limitations: - Most data for microRNAs, including MIR5189, are limited to sequence annotation without extensive functional characterization. - The lack of experimental, clinical, or pharmacological studies for MIR5189 should be considered when interpreting bioinformatic search results for this locus.
Not applicable / none known for MIR5189. MicroRNAs generally function via RNA-induced silencing complex (RISC)-mediated post-transcriptional gene silencing. No evidence that MIR5189 is a therapeutic drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 5189 (MIR5189).